Cite
HARVARD Citation
Rodriguez Abreu, D. et al. (n.d.). 1464PKEYNOTE-189 study of pembrolizumab (pembro) plus pemetrexed (pem) and platinum vs placebo plus pem and platinum for untreated, metastatic, nonsquamous NSCLC: Does choice of platinum affect outcomes?. Annals of oncology. p. . [Online].